Posted by Lindsey Winhoffer on Jan 3rd, 2025
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 9,650,000 shares, a growth of 5.3% from the November...
More of this article »